Ironwood Pharmaceuticals, Inc. Financial Ratios — IRWD Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-25.42	-33.09	-107.22	-62.35	-30.08	-12.3	-17.78	-60.22	5.85	22.07	62.68	15.72	-127.54	0.21	6.42
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-5.01	-12.53	- -	-48.61	- -	-0.13	-3.24
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	42.14	36.15	- -	16.15	- -	0.39	12.82
Gross Margin (%)	100	99.36	68.52	93.08	99.99	99.32	93.6	90.55	94.43	99.19	100	100	100	100	100
EBITDA Margin (%)	-85.23	-40.89	-1,050.1	-178.9	-48.69	-11.1	-11.3	-0.86	28.62	41.56	56.49	61.31	38.38	27.81	40.74
Operating Margin (%)	-100.41	-48.43	-1,101.36	-195.04	-56.47	-15.21	-15.54	-4.32	27.32	40.65	56.12	60.97	38.02	27.24	40.1
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	161.42	-106.14	304.96	-574.03	-255.14	79.52	-41.7
Pretax Margin (%)	-98.45	-48.34	-1,192.31	-248.07	-95.4	-29.83	-18.41	-56.01	13.76	27.95	48.5	61.48	-214.14	18.55	23.65
Profit Margin (%)	-98.45	-48.34	-1,192.31	-248.07	-95.4	-29.83	-39.2	-81.46	5.02	27.26	127.72	42.64	-226.37	0.25	8.11
Net Income to Common Margin (%)	-98.45	-48.34	-1,192.31	-248.07	-95.4	-29.83	-39.2	-81.46	5.02	27.26	127.72	42.64	-226.37	0.25	8.11
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.47	- -	30.65	- -	98.65	65.7
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	1	1	179	173	381	373	400	414	431	454	476	416	716	599	598
ST Debt	- -	- -	1	12	28	6	4	48	1	3	120	3	203	3	203
LT Debt	- -	- -	178	161	354	367	396	366	430	451	356	413	513	596	395
Total Debt/EBITDA	-0.01	-0.01	-0.74	-1.27	-5.24	-12.26	-11.87	-138.48	3.52	2.8	2.04	1.65	4.21	6.13	4.96
Net Debt/EBITDA	1.55	2.23	-0.41	-0.7	-1.61	-10.28	-8.02	-80.47	1.88	0.42	-0.71	-1.03	3.56	5.07	3.06
Total Debt/EBIT	-0.01	-0.01	-0.71	-1.16	-4.52	-8.95	-8.63	-27.67	3.68	2.87	2.05	1.66	4.25	6.26	5.03
Net Debt/EBIT	1.32	1.88	-0.39	-0.64	-1.39	-7.5	-5.83	-16.08	1.97	0.43	-0.71	-1.04	3.6	5.18	3.11
EBITDA to Interest Expense	-891.16	-1,041.31	-11.44	-6.46	-2.34	-0.78	-0.93	-0.08	3.35	5.49	7.5	33.13	7.86	2.96	3.68
EBITDA-CapEx/Interest Expense	-1,044.84	-1,278.24	-11.9	-6.63	-2.47	-3.44	-1	-0.09	3.15	5.43	7.49	33.12	7.84	2.95	3.68
EBIT to Interest Expense	-1,049.87	-1,233.25	-12	-7.04	-2.72	-1.06	-1.27	-0.4	3.2	5.37	7.45	32.95	7.78	2.9	3.63
Interest Expense	- -	- -	21	21	31	39	36	38	37	29	31	8	22	33	33
Common Equity/Total Assets	-206.86	-219.61	-278.79	-293.73	-179.28	-167.88	-216.06	-479.14	-390.34	-262.12	-83.19	-63.26	-360.55	-483.77	-421.66
Long-Term Debt/Equity (%)	0.38	0.21	465.16	181.5	372.03	549.45	4,022.05	- -	- -	719.31	58.72	63.28	- -	- -	- -
Long-Term Debt/Capital (%)	-0.1	-0.06	-29.7	-20.24	-48.58	-44.77	-43.6	-31.12	-37.7	-44.51	-77.08	-147.28	-52.18	-54.3	-36.71
Long-Term Debt/Total Assets (%)	0.2	0.13	63.74	48.8	57.16	51.64	65.4	110.31	106.79	80.57	31.57	37.51	108.87	169.93	99.49
Total Debt/Equity (%)	0.6	0.39	468.14	195.51	401.04	558.79	4,063.44	-210.79	-462.43	724.3	78.53	63.75	-206.63	-198.94	-228.31
Total Debt/Capital (%)	-0.15	-0.11	-29.89	-21.8	-52.37	-45.53	-44.05	-35.17	-37.8	-44.82	-103.07	-148.38	-72.8	-54.59	-55.57
Total Debt/Total Assets (%)	0.31	0.25	64.15	52.57	61.62	52.52	66.07	124.66	107.07	81.13	42.22	37.79	151.9	170.84	150.62
Net Debt to Equity	-79.45	-94.9	259.47	107.4	123.27	468.39	2,745.28	-122.48	-247.69	108.07	-27.39	-39.85	-174.91	-164.41	-141.01
Net Debt/Capital (%)	16.82	21.32	-14.71	-10.95	-11.85	-35.8	-26.14	-17.81	-17.53	-4.92	15.34	27.76	-56.34	-41.75	-28.6
EBITDA	-56	-61	-240	-137	-73	-30	-34	-3	123	162	234	252	170	98	121
EBITDA-CapEx	-66	-75	-250	-140	-77	-135	-37	-3	115	160	233	252	170	98	121
Operating Income (Loss)	-66	-73	-252	-149	-84	-42	-46	-15	117	158	232	250	168	96	119

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	2.52	3.06	4.81	4.1	5.75	3.35	3.35	1.45	4.33	11.27	3.84	25.71	0.33	2.28	0.89
Current Ratio	2.57	3.36	5.58	4.76	6.54	4.17	4.72	2.23	7.5	15.41	4.61	30.58	0.84	4.69	1.13
Quick Ratio	2.53	3.09	4.89	4.53	6.46	4.06	4.6	2.13	7.19	15.07	4.54	30.23	0.8	4.39	1.08
CFO/Avg Current Liab	-1.16	-1.16	-5.7	-3.06	-1.56	-0.31	-1.28	-0.76	0.13	4.62	2.7	2.92	1.22	0.66	0.9
Common Equity/Total Assets	-206.86	-219.61	-278.79	-293.73	-179.28	-167.88	-216.06	-479.14	-390.34	-262.12	-83.19	-63.26	-360.55	-483.77	-421.66
Long-Term Debt/Equity (%)	0.38	0.21	465.16	181.5	372.03	549.45	4,022.05	- -	- -	719.31	58.72	63.28	- -	- -	- -
Long-Term Debt/Capital (%)	-0.1	-0.06	-29.7	-20.24	-48.58	-44.77	-43.6	-31.12	-37.7	-44.51	-77.08	-147.28	-52.18	-54.3	-36.71
Long-Term Debt/Total Assets (%)	0.2	0.13	63.74	48.8	57.16	51.64	65.4	110.31	106.79	80.57	31.57	37.51	108.87	169.93	99.49
Total Debt/Equity (%)	0.6	0.39	468.14	195.51	401.04	558.79	4,063.44	-210.79	-462.43	724.3	78.53	63.75	-206.63	-198.94	-228.31
Total Debt/Capital (%)	-0.15	-0.11	-29.89	-21.8	-52.37	-45.53	-44.05	-35.17	-37.8	-44.82	-103.07	-148.38	-72.8	-54.59	-55.57
Total Debt/Total Assets (%)	0.31	0.25	64.15	52.57	61.62	52.52	66.07	124.66	107.07	81.13	42.22	37.79	151.9	170.84	150.62
CFO/Total Liabilities	-75.9	-81.11	-113.55	-64.61	-20.41	-4.03	-16.91	-13.41	2.16	34	50.27	61.09	22.44	15.88	19.29
CFO/CapEx	-7.77	-4.98	-28.5	-43.97	-26.41	-0.25	-35.94	-201.94	1.49	91.66	988.28	2,012.96	671.89	729.22	3,736.59
Altman's Z-Score	4.2	5.45	-2.64	0.68	-0.01	-0.1	-0.88	-3.5	-0.18	1.15	2.68	3.62	-1.76	-3.77	-3.6

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	37.14	140.48	9.74	5.26	3.72	4.59	4.06	4.25	4.32	3.25	3.5	3.58	3.62	3.33	4.6
Days Sales Outstanding	9.83	2.6	37.49	69.37	98.06	79.52	89.95	85.87	84.43	112.26	104.27	102.01	100.82	109.58	79.27
Inventory Turnover	- -	0.29	0.5	0.39	- -	3.46	21.03	89.12	73.69	9.68	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	1,266.91	730.81	934.71	75,342.08	105.61	17.35	4.1	4.95	37.71	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	0.54	1.42	-1.19	-0.54	0.22	1.11	2.08	2.41	0.81	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	670.61	257.15	-305.94	-677.67	1,627.09	327.62	175.85	151.65	450.97	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	598.9	511.15	1,310.02	76,117.81	-1,441.96	-220.31	-85.88	-62.27	-301	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	-1,264.31	-693.32	-865.35	-75,244.02	-26.09	72.59	81.78	79.48	74.55	- -	- -	- -	- -	- -
Inventories	- -	7	22	5	- -	1	1	- -	1	- -	- -	- -	- -	- -	- -
Raw Materials	- -	7	22	5	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	1,196	1,179	1,345	2,096	1,648	2,231	2,233	1,581	2,045	1,816	1,892	1,913	1,778	705	545
- Cash & Cash Equivalents	87	137	75	74	261	54	126	173	177	363	620	656	92	89	215
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	1	179	173	381	373	400	414	431	454	476	416	716	599	598
Enterprise Value	1,032	1,011	1,326	2,021	1,590	2,299	2,412	1,822	2,299	1,907	1,747	1,672	2,402	1,216	928
Total Capital	-432	-504	-599	-794	-728	-819	-908	-1,177	-1,141	-1,012	-462	-280	-983	-1,098	-1,076
Total Debt/Capital (%)	-0.15	-0.11	-29.89	-21.8	-52.37	-45.53	-44.05	-35.17	-37.8	-44.82	-103.07	-148.38	-72.8	-54.59	-55.57
Total Debt / EV	- -	- -	0.13	0.09	0.24	0.16	0.17	0.23	0.19	0.24	0.27	0.25	0.3	0.49	0.64
EV/Sales	15.67	6.73	57.97	26.44	10.63	8.39	8.09	5.26	5.37	4.9	4.22	4.07	5.42	3.46	3.13
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	18.75	11.78	7.48	6.64	14.13	12.44	7.69
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	19.64	12.05	7.53	6.68	14.27	12.7	7.81
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	173.88	- -	- -	48.57	9.65	5.08	5.99	11.6	11.69	6.71
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	19.57	- -	- -	42.17	9.56	5.08	5.99	11.59	11.67	6.71
Diluted Market Cap	1,196	1,179	1,345	2,096	1,648	2,231	2,233	1,581	2,077	1,830	1,917	2,308	1,778	709	549
Diluted Enterprise Value	1,109	1,043	1,448	2,195	1,768	2,550	2,508	1,822	2,331	1,921	1,773	2,068	2,402	1,220	932
EV per Share	10.33	9.5	11.45	14.77	11.18	15.75	16.19	11.94	14.96	11.96	10.77	10.83	15.45	7.64	5.73
TTM Sales	66	150	23	76	150	274	298	347	428	390	414	411	443	351	296
TTM EBITDA	-56	-61	-240	-137	-73	-30	-34	-3	123	162	234	252	170	98	121
TTM Operating Income	-66	-73	-252	-149	-84	-42	-46	-15	117	158	232	250	168	96	119
TTM Cash Flow to Firm	-75	-70	-252	-134	-76	13	-64	-33	47	198	344	279	207	104	138
TTM Free Cash Flow to Firm	-65	-56	-243	-131	-72	117	-62	-33	55	199	344	279	207	104	138

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-18.24	-21.18	-5.1	-13.79	-16.01	28.5	-22.8	-22.42	115.92	10.72	7.31	8.43	9.68	6.84	4.32
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	19.64	12.05	7.53	6.68	14.27	12.7	7.81
Enterprise Value	1,032	1,011	1,326	2,021	1,590	2,299	2,412	1,822	2,299	1,907	1,747	1,672	2,402	1,216	928
Low Price	9.97	10.01	8.95	9.01	9.77	7.35	13.43	9.07	7.91	7.99	8.78	9.73	8.07	3.06	0.53
EV/Sales	15.67	6.73	57.97	26.44	10.63	8.39	8.09	5.26	5.37	4.9	4.22	4.07	5.42	3.46	3.13
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	18.75	11.78	7.48	6.64	14.13	12.44	7.69
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	95.07	17.1	3.58	10.93	- -	800.84	22.71
Price/Earnings Average	-20.24	-18.65	-5.49	-9.7	-12.98	-22.61	-20.93	-8.81	80.75	16.08	3.63	10.12	-1.61	1,283.77	11.43
Price/Earnings High	-25.41	-23.32	-8.35	-11.51	-17.05	-30.16	-25.41	-11.46	108.64	21.11	4.38	11.42	-1.96	2,838.19	32.21
Price/Earnings Low	-15.35	-14.67	-3.8	-6.5	-9.73	-13.13	-17.11	-4.9	56.5	12	2.7	8.58	-1.25	553.17	3.55
Price/Book Value	-2.77	-2.33	-1.73	-2.17	-1.48	-1.87	-1.71	-0.99	-1.3	-1.24	-2.02	-2.75	-1.05	-0.42	-0.33
Price/Book Value Average	-3.04	-2.68	-1.93	-1.9	-1.67	-1.55	-1.87	-1.56	-1.1	-1.16	-2.05	-2.55	-0.95	-0.67	-0.16
Price/Book Value High	-3.81	-3.35	-2.93	-2.26	-2.19	-2.07	-2.27	-2.03	-1.49	-1.53	-2.47	-2.87	-1.16	-1.47	-0.46
Price/Book Value Low	-2.3	-2.11	-1.33	-1.27	-1.25	-0.9	-1.53	-0.87	-0.77	-0.87	-1.52	-2.16	-0.74	-0.29	-0.05
Price/Tangible Book Value	10.88	8.18	35.19	23.67	17.32	-22.27	-14.81	-8.02	-21.74	28.99	3.12	2.93	-5.08	-2.32	-2.07
Price/Tangible Book Value Average	11.95	9.4	39.18	20.76	19.46	-18.44	-16.22	-12.62	-18.47	27.26	3.16	2.72	-4.62	-3.71	-1.04
Price/Tangible Book Value High	15	11.76	59.62	24.64	25.57	-24.6	-19.7	-16.41	-24.85	35.78	3.82	3.06	-5.62	-8.21	-2.93
Price/Tangible Book Value Low	9.06	7.39	27.13	13.92	14.6	-10.7	-13.27	-7.02	-12.92	20.34	2.35	2.3	-3.59	-1.6	-0.32
Price/Sales	18.15	7.85	58.78	27.42	11.02	8.14	7.49	4.56	4.77	4.66	4.57	4.66	4.02	2.01	1.84
Price/Sales Average	19.93	9.02	65.45	24.05	12.38	6.74	8.2	7.18	4.05	4.38	4.63	4.32	3.65	3.21	0.93
Price/Sales High	25.02	11.27	99.59	28.55	16.26	9	9.96	9.33	5.45	5.75	5.6	4.87	4.44	7.11	2.61
Price/Sales Low	15.12	7.09	45.32	16.13	9.29	3.91	6.71	3.99	2.84	3.27	3.44	3.66	2.83	1.39	0.29
Price/Cash Flow	-15.89	-16.93	-4.92	-13.47	-15.41	-86.02	-22.17	-22.31	190.63	10.76	7.22	6.99	9.69	6.81	4.29
Price/Cash Flow Average	-17.45	-19.45	-5.48	-11.82	-17.31	-71.23	-24.29	-35.1	161.92	10.11	7.32	6.47	8.82	10.91	2.16
Price/Cash Flow High	-21.9	-24.33	-8.34	-14.03	-22.75	-95.02	-29.49	-45.65	217.84	13.28	8.84	7.3	10.73	24.12	6.09
Price/Cash Flow Low	-13.23	-15.3	-3.79	-7.92	-12.99	-41.35	-19.86	-19.53	113.29	7.54	5.44	5.49	6.84	4.7	0.67
Price/Free Cash Flow Average	-20.02	-24.34	-5.68	-12.09	-17.99	23.6	-24.99	-35.27	98.47	10.08	7.41	7.81	8.8	10.96	2.18
Price/Free Cash Flow High	-25.14	-30.44	-8.64	-14.35	-23.64	31.48	-30.33	-45.88	132.47	13.23	8.95	8.81	10.71	24.24	6.13
Price/Free Cash Flow Low	-15.19	-19.14	-3.93	-8.11	-13.5	13.7	-20.43	-19.63	68.89	7.52	5.51	6.62	6.83	4.72	0.68
EV/Sales Average	18.61	8.11	69.97	25.34	13.18	7.91	9.12	7.87	4.65	4.62	4.28	3.73	5.06	4.67	2.22
EV/Sales High	23.7	10.37	104.12	29.84	17.07	10.16	10.88	10.03	6.05	5.99	5.25	4.28	5.85	8.56	3.9
EV/Sales Low	13.8	6.18	49.84	17.42	10.09	5.08	7.63	4.69	3.43	3.5	3.09	3.07	4.24	2.84	1.58
EV/EBITDA Average	-21.84	-19.83	-6.66	-14.17	-27.07	-71.24	-80.74	-912.83	16.24	11.11	7.59	6.08	13.19	16.79	5.44
EV/EBITDA High	-27.81	-25.36	-9.91	-16.68	-35.05	-91.54	-96.28	-1,163.13	21.13	14.41	9.29	6.99	15.25	30.78	9.58
EV/EBITDA Low	-16.19	-15.12	-4.75	-9.74	-20.72	-45.76	-67.5	-543.71	11.98	8.43	5.48	5.01	11.06	10.21	3.88
EV/EBIT Average	-18.54	-16.75	-6.35	-12.99	-23.34	-51.99	-58.7	-182.39	17.01	11.36	7.63	6.12	13.31	17.14	5.53
EV/EBIT High	-23.61	-21.41	-9.45	-15.3	-30.22	-66.8	-70	-232.41	22.13	14.73	9.35	7.03	15.39	31.43	9.73
EV/EBIT Low	-13.75	-12.77	-4.53	-8.93	-17.87	-33.39	-49.08	-108.64	12.55	8.62	5.51	5.04	11.16	10.42	3.94
Last Price	11.97	11.08	11.61	15.32	11.59	15.29	14.99	10.36	13.31	11.39	11.66	12.39	11.44	4.43	3.37
High Price	16.5	15.92	19.67	15.95	17.11	16.89	19.94	21.2	15.21	14.06	14.27	12.95	12.66	15.7	4.78
Enterprise Value Average	1,226	1,219	1,601	1,937	1,971	2,166	2,722	2,728	1,991	1,799	1,773	1,532	2,241	1,641	657
Enterprise Value High	1,561	1,558	2,382	2,281	2,552	2,783	3,245	3,477	2,591	2,333	2,171	1,759	2,591	3,009	1,156
Enterprise Value Low	909	929	1,140	1,331	1,509	1,391	2,275	1,625	1,469	1,365	1,280	1,262	1,879	998	468

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	101	108	121	141	143	147	150	154	158	161	162	154	156	160	163
Diluted Weighted Avg Shares	100	106	116	137	142	146	149	153	156	161	164	186	155	160	163
Basic Weighted Avg Shares	100	106	116	137	142	146	149	153	154	159	162	154	155	159	162
Revenue per Share	0.66	1.41	0.2	0.56	1.05	1.88	2	2.27	2.79	2.44	2.55	2.66	2.85	2.21	1.83
EBITDA per Share	-0.56	-0.58	-2.07	-1	-0.51	-0.21	-0.23	-0.02	0.8	1.02	1.44	1.63	1.09	0.61	0.75
Operating Income per Share	-0.66	-0.68	-2.18	-1.09	-0.59	-0.29	-0.31	-0.1	0.76	0.99	1.43	1.62	1.08	0.6	0.73
Basic EPS, GAAP	-0.65	-0.68	-2.35	-1.39	-1	-0.56	-0.78	-1.85	0.14	0.67	3.26	1.13	-6.45	0.01	0.15
Basic EPS from Cont Ops	-0.65	-0.68	-2.35	-1.39	-1	-0.56	-0.37	-1.27	0.38	0.67	3.26	1.13	-6.64	0.01	0.15
Diluted EPS, GAAP	-0.65	-0.68	-2.35	-1.39	-1	-0.56	-0.78	-1.85	0.14	0.66	3.21	0.94	-6.45	0.01	0.15
Diluted EPS from Cont Ops	-0.65	-0.68	-2.35	-1.39	-1	-0.56	-0.37	-1.27	0.38	0.66	3.21	0.94	-6.64	0.01	0.15
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.75	-0.65	-2.36	-1.14	-0.75	-0.18	-0.68	-0.46	0.07	1.06	1.61	1.77	1.18	0.65	0.78
Free Cash Flow per Basic Share	-0.85	-0.79	-2.44	-1.16	-0.78	-0.89	-0.7	-0.47	0.02	1.05	1.61	1.77	1.18	0.65	0.78
Cash & Equivalents per Share	1.64	1.58	1.71	1.82	3.09	2.09	1.49	1.13	1.15	2.27	3.82	4.25	0.59	0.56	1.33
Book Value per Share	-4.33	-4.75	-6.71	-7.07	-7.81	-8.17	-8.78	-10.42	-10.23	-9.19	-5.78	-4.51	-10.93	-10.67	-10.34
Tangible Book Value per Share	1.1	1.35	0.33	0.65	0.67	-0.69	-1.01	-1.29	-0.61	0.39	3.73	4.23	-2.25	-1.91	-1.63

Ironwood Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)